Answers are grounded in this paper and cite their sources.
FCM classifies leukocytes to effectively detect acute leukemia and monitor treatment outcomes.
FCM-based PBL classification is precise and efficient for detecting blasts, providing rapid subtype identification. Its strong correlation with marrow findings underscores its clinical utility in AL screening and monitoring.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: